142 related articles for article (PubMed ID: 16733863)
1. Expression of cyclooxygenase-2 is associated with p53 accumulation in premalignant and malignant gallbladder lesions.
Legan M; Luzar B; Marolt VF; Cor A
World J Gastroenterol; 2006 Jun; 12(21):3425-9. PubMed ID: 16733863
[TBL] [Abstract][Full Text] [Related]
2. p53 protein overexpression in gallbladder carcinoma and its precursor lesions: an immunohistochemical study.
Wistuba II; Gazdar AF; Roa I; Albores-Saavedra J
Hum Pathol; 1996 Apr; 27(4):360-5. PubMed ID: 8617479
[TBL] [Abstract][Full Text] [Related]
3. Expression of human telomerase catalytic protein in gallbladder carcinogenesis.
Luzar B; Poljak M; Cör A; Klopcic U; Ferlan-Marolt V
J Clin Pathol; 2005 Aug; 58(8):820-5. PubMed ID: 16049283
[TBL] [Abstract][Full Text] [Related]
4. Expression of COX-2 is associated with accumulation of p53 in pancreatic cancer: analysis of COX-2 and p53 expression in premalignant and malignant ductal pancreatic lesions.
Hermanova M; Trna J; Nenutil R; Dite P; Kala Z
Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):732-9. PubMed ID: 18617777
[TBL] [Abstract][Full Text] [Related]
5. p53 gene mutation and protein accumulation during neoplastic progression in Barrett's esophagus.
Bian YS; Osterheld MC; Bosman FT; Benhattar J; Fontolliet C
Mod Pathol; 2001 May; 14(5):397-403. PubMed ID: 11353048
[TBL] [Abstract][Full Text] [Related]
6. Expression of cyclooxygenase-2 and its relationship to p53 accumulation in ovarian adenocarcinomas.
Shigemasa K; Tian X; Gu L; Shiroyama Y; Nagai N; Ohama K
Int J Oncol; 2003 Jan; 22(1):99-105. PubMed ID: 12469191
[TBL] [Abstract][Full Text] [Related]
7. [Expression of p53 in gallbladder carcinoma and in dysplastic and metaplastic lesions of the surrounding mucosa].
Billo P; Marchegiani C; Capella C; Sessa F
Pathologica; 2000 Aug; 92(4):249-56. PubMed ID: 11029885
[TBL] [Abstract][Full Text] [Related]
8. [An early carcinoma of the gallbladder with atypical epithelium ( a report of a case with elevated p53 expression)].
Yabar HA; Watanabe H
Rev Gastroenterol Peru; 1994; 14(1):65-8. PubMed ID: 8018902
[TBL] [Abstract][Full Text] [Related]
9. Clinical importance of p53 protein in gall bladder carcinoma and its precursor lesions.
Wee A; Teh M; Raju GC
J Clin Pathol; 1994 May; 47(5):453-6. PubMed ID: 8027399
[TBL] [Abstract][Full Text] [Related]
10. Expression of cyclooxygenase-2 in colorectal adenocarcinoma is associated with p53 accumulation and hdm2 overexpression.
Cressey R; Pimpa S; Tontrong W; Watananupong O; Leartprasertsuke N
Cancer Lett; 2006 Feb; 233(2):232-9. PubMed ID: 15921850
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic significance of nuclear p53 expression in the surveillance of Barrett's esophagus--a longitudinal study.
Klump B; Hsieh CJ; Holzmann K; Borchard F; Gaco V; Greschniok A; Eckardt VF; Bettendorf U; Gregor M; Porschen R
Z Gastroenterol; 1999 Oct; 37(10):1005-11. PubMed ID: 10549095
[TBL] [Abstract][Full Text] [Related]
12. p53, carcinoembryonic antigen and carbohydrate antigen 19.9 expression in gall bladder cancer, precursor epithelial lesions and xanthogranulomatous cholecystitis.
Agrawal V; Goel A; Krishnani N; Pandey R; Agrawal S; Kapoor VK
J Postgrad Med; 2010; 56(4):262-6. PubMed ID: 20935395
[TBL] [Abstract][Full Text] [Related]
13. High-grade dysplasia and superficial adenocarcinoma in Barrett's esophagus: histological mapping and expression of p53, p21 and Bcl-2 oncoproteins.
Chatelain D; Fléjou JF
Virchows Arch; 2003 Jan; 442(1):18-24. PubMed ID: 12536310
[TBL] [Abstract][Full Text] [Related]
14. p53 protein expression and prognosis in gallbladder carcinoma and premalignant lesions.
Ajiki T; Onoyama H; Yamamoto M; Asaka K; Fujimori T; Maeda S; Saitoh Y
Hepatogastroenterology; 1996; 43(9):521-6. PubMed ID: 8799388
[TBL] [Abstract][Full Text] [Related]
15. COX-2 and p53 in human sinonasal cancer: COX-2 expression is associated with adenocarcinoma histology and wood-dust exposure.
Holmila R; Cyr D; Luce D; Heikkilä P; Dictor M; Steiniche T; Stjernvall T; Bornholdt J; Wallin H; Wolff H; Husgafvel-Pursiainen K
Int J Cancer; 2008 May; 122(9):2154-9. PubMed ID: 18186150
[TBL] [Abstract][Full Text] [Related]
16. The expression of p53 and COX-2 in basal cell carcinoma, squamous cell carcinoma and actinic keratosis cases.
Karagece Yalçin U; Seçkın S
Turk Patoloji Derg; 2012; 28(2):119-27. PubMed ID: 22627629
[TBL] [Abstract][Full Text] [Related]
17. Aneuploidy and overexpression of Ki67 and p53 as markers for neoplastic progression in Barrett's esophagus: a case-control study.
Sikkema M; Kerkhof M; Steyerberg EW; Kusters JG; van Strien PM; Looman CW; van Dekken H; Siersema PD; Kuipers EJ
Am J Gastroenterol; 2009 Nov; 104(11):2673-80. PubMed ID: 19638963
[TBL] [Abstract][Full Text] [Related]
18. Cyclooxygenase-2 expression determines neo-angiogenesis in gallbladder carcinomas.
Legan M; Luzar B; Ferlan-Marolt V; Cör A
Bosn J Basic Med Sci; 2006 Nov; 6(4):58-63. PubMed ID: 17177652
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of COX-2, P53, and EZH-2 evaluated by quantitative image analysis in premalignant and malignant breast lesions.
Nicolopoulou-Stamati P; Tsipis A; Chelidonis G; Patsouris E; Athanassiadou P; Gonidi M; Athanassiadou AM
Diagn Cytopathol; 2015 Apr; 43(4):294-300. PubMed ID: 25355039
[TBL] [Abstract][Full Text] [Related]
20. COX-2 expression during early lung squamous cell carcinoma oncogenesis.
Mascaux C; Martin B; Verdebout JM; Ninane V; Sculier JP
Eur Respir J; 2005 Aug; 26(2):198-203. PubMed ID: 16055866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
